Description: hsBCL9CT-24 serves as an inhibitor of the Wnt/β-catenin (β-cat) pathway and exhibits significant antitumor effects. This compound reactivates the anticancer immune response that is suppressed by the carcinogenic Wnt pathway, making it valuable for cancer research.